Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease

  • Codony, Sandra|||0000-0003-0539-673X
  • Pont, Caterina|||0000-0001-9118-0892
  • Griñán-Ferré, Christian|||0000-0002-5424-9130
  • Di Pede-Mattatelli, Ania
  • Calvó-Tusell, Carla|||0000-0003-2681-8460
  • Feixas, Ferran|||0000-0001-5147-0000
  • Osuna, Sílvia|||0000-0003-3657-6469
  • Jarné-Ferrer, Júlia
  • Naldi, Marina
  • Bartolini, Manuela|||0000-0002-2890-3856
  • Loza, María Isabel|||0000-0003-4730-0863
  • Brea, José|||0000-0002-5523-1979
  • Pérez, Belén|||0000-0001-5801-1704
  • Bartra, Clara
  • Sanfeliu i Pujol, Coral|||0000-0002-9004-1206
  • Juárez-Jiménez, Jordi|||0000-0003-1464-1397
  • Morisseau, Christophe
  • Hammock, Bruce D.|||0000-0003-1408-8317
  • Pallàs, Mercè|||0000-0003-3095-4254
  • Vázquez, Santiago|||0000-0002-9296-6026
  • Muñoz-Torrero López-Ibarra, Diego|||0000-0002-8140-8555
With innumerable clinical failures of target-specific drug candidates for multifactorial diseases, such as Alzheimer's disease (AD), which remains inefficiently treated, the advent of multitarget drug discovery has brought a new breath of hope. Here, we disclose a class of 6-chlorotacrine (huprine)-TPPU hybrids as dual inhibitors of the enzymes soluble epoxide hydrolase (sEH) and acetylcholinesterase (AChE), a multitarget profile to provide cumulative effects against neuroinflammation and memory impairment. Computational studies confirmed the gorge-wide occupancy of both enzymes, from the main site to a secondary site, including a so far non-described AChE cryptic pocket. The lead compound displayed in vitro dual nanomolar potencies, adequate brain permeability, aqueous solubility, human microsomal stability, lack of neurotoxicity, and it rescued memory, synaptic plasticity, and neuroinflammation in an AD mouse model, after low dose chronic oral administration.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Pentafluorosulfanyl-containing triclocarban analogs with potent antimicrobial activity

  • Pujol Bech, Eugenia|||0000-0003-1941-0539
  • Blanco-Cabra, Núria
  • Julián, Esther|||0000-0002-6558-3978
  • Leiva, Rosana
  • Torrents, Eduard|||0000-0002-3010-1609
  • Vázquez, Santiago|||0000-0002-9296-6026
Concerns have been raised about the long-term accumulating effects of triclocarban, a polychlorinated diarylurea widely used as an antibacterial soap additive, in the environment and in human beings. Indeed, the Food and Drug Administration has recently banned it from personal care products. Herein, we report the synthesis, antibacterial activity and cytotoxicity of novel N,N'-diarylureas as triclocarban analogs, designed by reducing one or more chlorine atoms of the former and/or replacing them by the novel pentafluorosulfanyl group, a new bioisostere of the trifluoromethyl group, with growing importance in drug discovery. Interestingly, some of these pentafluorosulfanyl-bearing ureas exhibited high potency, broad spectrum of antimicrobial activity against Gram-positive bacterial pathogens, and high selectivity index, while displaying a lower spontaneous mutation frequency than triclocarban. Some lines of evidence suggest a bactericidal mode of action for this family of compounds.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Neuroprotective effects of the multitarget agent AVCRI104P3 in brain of middle-aged mice

  • Relat Pardo, Júlia
  • Come, Julio
  • Pérez, Belén|||0000-0001-5801-1704
  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Muñoz-Torrero López-Ibarra, Diego|||0000-0002-8140-8555
  • Badía, A. (Albert)
  • Gimenez-Llort, Lydia|||0000-0002-4091-489X
  • Clos, M. Victoria
Molecular factors involved in neuroprotection are key in the design of novel multitarget drugs in aging and neurodegeneration. AVCRI104P3 is a huprine derivative that exhibits potent inhibitory effects on human AChE, BuChE, and BACE-1 activities, as well as on AChE-induced and self-induced Aβ aggregation. More recently, cognitive protection and anxiolytic-like effects have also been reported in mice treated with this compound. Now, we have assessed the ability of AVCRI104P3 (0.43 mg/kg, 21 days) to modulate the levels of some proteins involved in the anti-apoptotic/apoptotic processes (pAkt1, Bcl2, pGSK3β, p25/p35), inflammation (GFAP and Iba1) and neurogenesis in C57BL/6 mice. The effects of AVCRI104P3 on AChE-R/AChE-S isoforms have been also determined. We have observed that chronic treatment of C57BL/6 male mice with AVCRI104P3 results in neuroprotective effects, increasing significantly the levels of pAkt1 and pGSK3β in the hippocampus and Bcl2 in both hippocampus and cortex, but slightly decreasing synaptophysin levels. Astrogliosis and neurogenic markers GFAP and DCX remained unchanged after AVCRI104P3 treatment, whereas microgliosis was found to be significantly decreased pointing out the involvement of this compound in inflammatory processes. These results suggest that the neuroprotective mechanisms that are behind the cognitive and anxiolytic effects of AVCRI104P3 could be partly related to the potentiation of some anti-apoptotic and anti-inflammatory proteins and support the potential of AVCRI104P3 for the treatment of brain dysfunction associated with aging and/or dementia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clock/Sleep-Dependent Learning and Memory in Male 3xTg-AD Mice at Advanced Disease Stages and Extrinsic Effects of Huprine X and the Novel Multitarget Agent AVCRI104P3

  • Gimenez-Llort, Lydia|||0000-0002-4091-489X
  • Santana-Santana, Mikel
  • Ratia, Míriam
  • Pérez, Belén|||0000-0001-5801-1704
  • Camps García, Pelayo|||0000-0002-9633-3525
  • Muñoz-Torrero López-Ibarra, Diego|||0000-0002-8140-8555
  • Badía, A. (Albert)
  • Clos Guillen, Maria Victoria|||0000-0002-7389-3351
A new hypothesis highlights sleep-dependent learning/memory consolidation and regards the sleep-wake cycle as a modulator of β-amyloid and tau Alzheimer's disease (AD) pathologies. Sundowning behavior is a common neuropsychiatric symptom (NPS) associated with dementia. Sleep fragmentation resulting from disturbances in sleep and circadian rhythms in AD may have important consequences on memory processes and exacerbate the other AD-NPS. The present work studied the effect of training time schedules on 12-month-old male 3xTg-AD mice modeling advanced disease stages. Their performance in two paradigms of the Morris water maze for spatial-reference and visual-perceptual learning and memory were found impaired at midday, after 4 h of non-active phase. In contrast, early-morning trained littermates, slowing down from their active phase, exhibited better performance and used goal-directed strategies and non-search navigation described for normal aging. The novel multitarget anticholinesterasic compound AVCRI104P3 (0.6 µmol·kg-1, 21 days i.p.) exerted stronger cognitive benefits than its in vitro equipotent dose of AChEI huprine X (0.12 μmol·kg-1, 21 days i.p.). Both compounds showed streamlined drug effectiveness, independently of the schedule. Their effects on anxiety-like behaviors were moderate. The results open a question of how time schedules modulate the capacity to respond to task demands and to assess/elucidate new drug effectiveness.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

AAV-mediated expression of secreted and transmembrane αKlotho isoforms rescues relevant aging hallmarks in senescent SAMP8 mice

  • Roig-Soriano, Joan|||0000-0002-6134-3141
  • Griñán-Ferré, Christian|||0000-0002-5424-9130
  • Espinosa-Parrilla, J. F.|||0000-0001-6631-3542
  • Abraham, Carmela R|||0000-0002-6649-1960
  • Bosch i Merino, Assumpció|||0000-0002-7205-2796
  • Pallàs, Mercè|||0000-0003-3095-4254
  • Chillón Rodríguez, Miguel|||0000-0003-0840-2111
Senescence represents a stage in life associated with elevated incidence of morbidity and increased risk of mortality due to the accumulation of molecular alterations and tissue dysfunction, promoting a decrease in the organism's protective systems. Thus, aging presents molecular and biological hallmarks, which include chronic inflammation, epigenetic alterations, neuronal dysfunction, and worsening of physical status. In this context, we explored the AAV9-mediated expression of the two main isoforms of the aging-protective factor Klotho (KL) as a strategy to prevent these general age-related features using the senescence-accelerated mouse prone 8 (SAMP8) model. Both secreted and transmembrane KL isoforms improved cognitive performance, physical state parameters, and different molecular variables associated with aging. Epigenetic landscape was recovered for the analyzed global markers DNA methylation (5-mC), hydroxymethylation (5-hmC), and restoration occurred in the acetylation levels of H3 and H4. Gene expression of pro- and anti-inflammatory mediators in central nervous system such as TNF-α and IL-10, respectively, had improved levels, which were comparable to the senescence-accelerated-mouse resistant 1 (SAMR1) healthy control. Additionally, this improvement in neuroinflammation was supported by changes in the histological markers Iba1, GFAP, and SA β-gal. Furthermore, bone tissue structural variables, especially altered during senescence, recovered in SAMP8 mice to SAMR1 control values after treatment with both KL isoforms. This work presents evidence of the beneficial pleiotropic role of Klotho as an anti-aging therapy as well as new specific functions of the KL isoforms for the epigenetic regulation and aged bone structure alteration in an aging mouse model. Intraventricular administration of AAV vectors expressing secreted and transmembrane Klotho isoforms, rescued accelerated aging phenotype of SAMP8 mice. An improvement in cognitive and physical performance, recovery of epigenetic, inflammatory and senescence markers, as well as structural changes in long bones of these mice was detected.